← Product recalls

CPSC Official Notice

Plantimex Recalls Mamisan Lidocaine Ointment Containers Due to Risk of Serious Injury or Death from Child Poisoning; Violates Mandatory Standard for Child-Resistant Packaging

Recall 26157 · December 18, 2025

Hazard
The ointment contains lidocaine, which must be in child-resistant packaging, as required by the Poison Prevention Packaging Act. The ointment's packaging is not child-resistant, posing a risk of serious injury or death from poisoning if the contents are swallowed by young children.
Remedy
Consumers should immediately secure the recalled ointment jars out of the sight and reach of children and contact Plantimex to receive a free replacement lid. Once the product is secured with the replacement lid, consumers can use the product, as directed.
Units
Not reported
Consumer contact
Plantimex toll-free at 855-752-6869 from 9 a.m. to 4 p.m. PT Monday through Friday, email at customercare@plantimexusa.com with the subject "RECALL" or online at http://plantimexusa.com/contact.php or www.plantimexusa.com and contact us for more information.

Recall description

This recall involves Mamisan Pain Relieving Topical Ointment jars. The ointment comes in an orange container with a white continuous thread lid and has the Mamisan trademark printed on top of the lid and on the label. The ointment was sold in a 3.52 ounce plastic jar. The wraparound label includes instructions and drug facts. Only jars with UPC code 860006498115 are included in the recall.

View official CPSC notice ↗

Community feedback

Was this information helpful?

Reader comments (0)

No comments yet. Start the conversation with a helpful, non-confidential note.

Leave a comment

Comments are reviewed before publication. Do not include confidential case details.